Home health stocks saw mixed success in February, according to the latest Home Health Index (HHI) from mergers-and-acquisitions advisory firm Stoneridge Partners. The up-and-down February follows a largely positive January. Updated monthly, the HHI by Stoneridge Partners tracks the market values for Amedisys Inc. (Nasdaq: AMED) and LHC Group Inc. (Nasdaq: LHCG). Overall, the HHI […]
Amedisys
Amedisys Inc. (Nasdaq: AMED) beat Wall Street expectations for the fourth quarter of 2018, a fitting end to what was an overwhelmingly positive year for the Baton Rouge, Louisiana-based home health company. More than four years removed from when its turnaround efforts began, the once-struggling Amedisys is now focused on growing its hospice and personal […]
Aveanna Healthcare to acquire Maxim’s home health care division Atlanta-based Aveanna Healthcare has entered into a definitive agreement to acquire the home health care division of Maxim Healthcare Services. Financial terms of the transaction — expected to close in the second quarter of 2019 — were not disclosed. Privately-owned Aveanna Healthcare is made up of […]
Amedisys Inc. (Nasdaq: AMED) took its first major step into the world of predictive analytics in August when it announced a minority investment in home health-focused data science firm Medalogix. The Baton Rouge, Louisiana-based company has now started to reap the rewards of that investment. During the past few months, Amedisys has been fine-tuning its […]
Amedisys Inc. (Nasdaq: AMED) — already one of the country’s largest independent home health providers — has closed on its $340 million acquisition of Compassionate Care Hospice. In doing so, the Baton Rouge, Louisiana-based company in one fell swoop dramatically expands its end-of-life care presence and becomes the third-largest hospice provider in the U.S. as […]
Baton Rouge, Louisiana-based Amedisys Inc. (Nasdaq: AMED), one of the largest independent home health care companies in the country, had a successful 2018 and is looking to maintain the momentum in the year ahead. The company’s ambitions include a heightened focus on risk-taking arrangements with payers and building on the tech investment it made in […]
December 2018 was the worst December for stock values since the Great Depression era. The two biggest publicly traded home health companies in the U.S. — Amedisys Inc. (Nasdaq: AMED) and LHC Group Inc. (Nasdaq: LHCG) — saw a market dip in stock values as well. That’s according to M&A advisory firm Stoneridge Partners’ latest […]
2018 was a banner year for the Medicare-certified home health care industry. Big providers got even larger through creative mergers and acquisitions. Admissions and utilization numbers held strong. New telehealth opportunities started to emerge. And, in general, revenues remained high. The upcoming year brings much uncertainty, however, with the main culprit being the Patient-Driven Groupings […]
From the introduction of the Patient-Driven Groupings Model (PDGM) to fine-tuning the nine-state Value-Based Purchasing Model (VBPM), 2018 was an important year for home health care at large. Next year will bring its own set of challenges and opportunities — some new and others old. Home health industry insiders and top executives expect Texas’ recent […]
Home Health Care News’ most-read stories of 2018 largely focused on Medicare Advantage changes, payment updates and regulatory initiatives. But every year there are also stories that don’t make our most-read list that we feel are deserving of another look. These stories highlight interesting trends, shed light on important topics and capture some of the […]